These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1815050)

  • 1. Design and evaluation of sustained-release tablets of lithium in a fat matrix and its bioavailability in humans.
    Llabrés M; Fariña JB
    J Pharm Sci; 1991 Nov; 80(11):1012-6. PubMed ID: 1815050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro and in vivo performance of two sustained-release lithium carbonate matrix tablets. Effect of different diets on the bioavailability.
    Gai MN; Ferj S; García E; Seitz C; Thielemann AM; Andonaegui MT
    Drug Dev Ind Pharm; 1999 Feb; 25(2):131-40. PubMed ID: 10065346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative analysis of the influence of different types of Carbopol on the release rate of lithium-carbonate from matrix tablets].
    Toskić-Radojcić M; Pavlović M; Gazikalović E; Arandjelović A; Kovacević A
    Vojnosanit Pregl; 2012 Aug; 69(8):675-80. PubMed ID: 22924263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets.
    Ciftçi K; Capan Y; Oztürk O; Hincal AA
    Pharm Res; 1990 Apr; 7(4):359-63. PubMed ID: 2114020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of lithium from lithium citrate syrup versus conventional lithium carbonate tablets.
    Guelen PJ; Janssen TJ; De Witte TC; Vree TB; Benson K
    Biopharm Drug Dispos; 1992 Oct; 13(7):503-11. PubMed ID: 1489941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
    Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
    Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of lithium following administration of slow-release and conventional preparations.
    Tyrer S; Hullin RP; Birch NJ; Goodwin JC
    Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability.
    Lin Q; Fu Y; Li J; Qu M; Deng L; Gong T; Zhang Z
    Eur J Pharm Sci; 2015 Nov; 79():44-52. PubMed ID: 26349052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
    Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
    Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose bioavailability of two extended-release lithium carbonate products.
    Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG
    Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and in vitro/in vivo evaluation of sustained-release floating tablets of itopride hydrochloride.
    Ahmed SM; Ahmed Ali A; Ali AM; Hassan OA
    Drug Des Devel Ther; 2016; 10():4061-4071. PubMed ID: 28008229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of 1-deoxynojirimycin sustained-release pellets vs conventional immediate-release tablets.
    Sun Z; Yuan S; Zhao H; Wang Z; Liu Z
    J Microencapsul; 2017 May; 34(3):293-298. PubMed ID: 28425304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tablets compressed with gastric floating pellets coated with acrylic resin for gastro retention and sustained release of famotidine: in-vitro and in-vivo study.
    Qi X; Jiang Y; Zhang H; Wu Z
    J Pharm Pharmacol; 2015 Apr; 67(4):493-500. PubMed ID: 25495700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of three different diets on the bioavailability of a sustained release lithium carbonate matrix tablet.
    Gai MN; Thielemann AM; Arancibia A
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):320-6. PubMed ID: 10890582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bioavailability of sustained-release and nonsustained-release isosorbide-5-mononitrate].
    Muck B; Bonn R; Rietbrock N
    Arzneimittelforschung; 1989 Oct; 39(10):1274-6. PubMed ID: 2610720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of lithium preparations in patients.
    Johnson GF; Hunt GE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of response surface methodology for the formulation and optimization of salbutamol sulfate hydrophilic matrix sustained release tablets.
    Chaibva FA; Walker RB
    Pharm Dev Technol; 2012; 17(5):594-606. PubMed ID: 21428702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.